QLTY GMO U.S. Quality ETF

ETF on NYSE (US) · Actively managed · Listing

Form N-PORT Aug 31, 2026 vs May 31, 2026 Filed with the SEC Oct 29, 2026
Book +15% $4.51B → $5.18B
Line items (May 31, 2026: 42) 44
In top 10 44%
Largest holding: Microsoft Corporation ($403M) 7.8%
Portfolio date Aug 31, 2026
New / increased 3 / 31
Reduced / closed 9 / 1
Unchanged 0
−13%

Most notable sale · Lam Research Corporation

Lam Research Corporation cut by 13%

Shares went from 761,302 to 659,259 ($242M → $199M). Now 3.8% of the portfolio. Estimated trade $30.8M.

New

Most notable buy · NVIDIA Corporation

New position in NVIDIA Corporation

607,934 shares worth $134M. Now 2.6% of the portfolio.

Largest holding: Microsoft Corporation, raised 11%, 795,334 shares ($403M).

Microsoft Corporation: 7.8% Alphabet Inc.: 4.9% Apple Inc.: 4.5% Johnson & Johnson: 4.4% Thermo Fisher Scientific Inc: 4.1% Lam Research Corporation: 3.8% Meta Platforms, Inc.: 3.8% Broadcom Inc.: 3.7% Amazon.com, Inc.: 3.6% Salesforce, Inc.: 3.4% The other 34 positions: 55.9% $5.18B Holdings value
Current positions Top 10 % of book
Microsoft Corporation MSFT $403M · +11% sh 7.8%
Alphabet Inc. GOOGL $251M · +11% sh 4.9%
Apple Inc. AAPL $235M · +1% sh 4.5%
Johnson & Johnson JNJ $227M · +1% sh 4.4%
Thermo Fisher Scientific Inc TMO $214M · +29% sh 4.1%
Lam Research Corporation LRCX $199M · −13% sh 3.8%
Meta Platforms, Inc. META $195M · +11% sh 3.8%
Broadcom Inc. AVGO $193M · +8% sh 3.7%
Amazon.com, Inc. AMZN $187M · +11% sh 3.6%
Salesforce, Inc. CRM $177M · +15% sh 3.4%

Slices are % of holdings value. Changes ("sh" shares, "units" other holdings) are in the quantity held against May 31, 2026.

Technology: 35.0% Healthcare: 23.7% Communication Services: 12.5% Financial Services: 8.5% Consumer Defensive: 7.1% Consumer Cyclical: 6.5% Industrials: 4.1% Unclassified: 2.7% 7 sectors
Sectors % of holdings value
Technology 35.0%
Healthcare 23.7%
Communication Services 12.5%
Financial Services 8.5%
Consumer Defensive 7.1%
Consumer Cyclical 6.5%
Industrials 4.1%
Unclassified 2.7%
Software - Application: 14.5% Internet Content & Information: 9.9% Semiconductors: 9.7% Drug Manufacturers - General: 8.5% Financial Data & Stock Exchanges: 6.6% Semiconductor Equipment & Materials: 6.3% Healthcare Plans: 5.5% Other (16): 36.4% Unclassified: 2.7% 23 industries
Industries % of holdings value
Software - Application 14.5%
Internet Content & Information 9.9%
Semiconductors 9.7%
Drug Manufacturers - General 8.5%
Financial Data & Stock Exchanges 6.6%
Semiconductor Equipment & Materials 6.3%
Healthcare Plans 5.5%
Other (16) 36.4%
Unclassified 2.7%
Initiations 3 Value
NVIDIA Corporation NVDA 2.6% of portfolio $134M
Philip Morris International Inc PM 1.0% of portfolio $51.0M
Stryker Corporation SYK 0.9% of portfolio $48.2M
Increases 31 Change
Netflix, Inc. NFLX $76.2M → $133M +86%
Thermo Fisher Scientific Inc TMO $133M → $214M +29%
Microsoft Corporation MSFT $323M → $403M +11%
Mastercard Incorporated MA $80.2M → $131M +36%
Alphabet Inc. GOOGL $254M → $251M +11%
Salesforce, Inc. CRM $114M → $177M +15%
Meta Platforms, Inc. META $194M → $195M +11%
Amazon.com, Inc. AMZN $176M → $187M +11%
Visa Inc. V $116M → $150M +11%
Broadcom Inc. AVGO $216M → $193M +8%
Eli Lilly and Company LLY $113M → $131M +10%
Accenture PLC $103M → $116M +11%
Reductions 9 Change
Lam Research Corporation LRCX $242M → $199M −13%
U.S. Bancorp USB $111M → $95.4M −23%
Merck & Company, Inc. MRK $82.4M → $83.5M −19%
KLA Corporation KLAC $179M → $125M −5%
Elevance Health, Inc. ELV $78.7M → $75.0M −4%
Procter & Gamble Company (The) PG $106M → $104M −3%
Hilton Worldwide Holdings Inc. HLT $93.7M → $88.2M −3%
UnitedHealth Group Incorporated UNH $128M → $131M −<1%
Abbott Laboratories ABT $103M → $133M −<1%
Terminations 1 Change
Mondelez International, Inc. MDLZ was $159K −100%

Source: the fund's quarterly portfolio reports to the SEC, the portfolio of Aug 31, 2026 (Form N-PORT) vs the portfolio of May 31, 2026 (Form N-PORT). Percent changes are changes in the quantity held (shares, or units for holdings that are not a listed equity); dollar values are as reported at each period end. Each column is ranked by the estimated dollar size of the trade: a new or closed position at its value, otherwise the change in shares at the position's own period-end price. Where shares and price per share moved by inverse whole multiples (a split), the earlier share count is restated. Cash and money-market lines are in the book and its value but are never counted as trades. Short positions are listed as such, at their (negative) printed value.

Objective

Total return.

Principal investment strategies

The Fund is an actively managed exchange-traded fund ("ETF") that seeks to achieve its investment objective by investing primarily in equities of U.S. companies that the Fund's adviser, Grantham, Mayo, Van Otterloo & Co. LLC ("GMO" or the "Adviser"), believes to be of high quality. GMO believes a high quality company generally to be a company that has an established business that will deliver a high level of return on past investments and that will use cash flows to make investments with the potential for a high return on capital or to return cash to shareholders through dividends or share buybacks. Equity securities primarily include common and preferred stocks and, to a lesser extent, other stock-related securities, such as convertible securities, depositary receipts, equity real estate investment trusts ("REITs"), income trusts, and securities of other investment companies that invest primarily in equity securities. In selecting securities for purchase and sale by the Fund, GMO uses a combination of investment methods, typically considering both (1) systematic factors, based on profitability, profit stability, leverage, and other publicly available financial information, and (2) judgmental factors, based on GMO's assessment of future profitability, capital allocation, growth opportunities, and sustainability against competitive forces. The weight that each systematic and judgmental factor is given for a particular security varies over time and GMO U.S. QUALITY ETF depends on GMO's assessment of the factor's materiality and relevance to that security. GMO also may rely on valuation methodologies, such as discounted cash flow analysis and multiples of price to earnings, revenues, book values or other fundamental metrics with the objective of buying higher quality stocks at a discount to what GMO believes to be their fundamental fair (or intrinsic) value. The Fund is not subject to any limit on the frequency with which portfolio securities may be purchased or sold, and GMO makes investment decisions for the Fund without regard to portfolio turnover rates. At times, the Fund may have substantial exposure to a single asset class, industry, sector, issuer, or companies with similar market capitalizations. The Fund may invest in securities of companies of any market capitalization. The factors GMO considers and investment methods GMO uses can change over time. GMO does not manage the Fund to, or control the Fund's risk relative to, any securities index or securities benchmark. As an alternative to investing directly in equities or in an attempt to obtain or adjust elements of its investment exposure, the Fund may invest in other ETFs. In addition, the Fund may lend its portfolio securities. Under normal circumstances, the Fund invests directly and indirectly at least 80% of its assets in equities of quality companies (see "Name Policies"). The term "quality company" means a company that (i) is included in an independently maintained index of quality companies ("Quality Index"); (ii) has financial and business characteristics that GMO determines to be similar to those of companies included in a Quality Index; or (iii) rates in the top 50% of GMO's quality rankings for companies within the Fund's investment universe. Under normal circumstances, the Fund invests directly and indirectly (e.g., through underlying funds) at least 80% of its assets in companies tied economically to the United States (see "Name Policies"). The Fund also may invest in GMO U.S. Treasury Fund, a mutual fund advised by GMO, or in money market funds unaffiliated with GMO, and directly in the types of investments typically held by money market funds.

Management and Contact

Adviser
Grantham, Mayo, Van Otterloo & Co. LLC
Portfolio managers

LLC Investment Team and Senior Members of GMO primarily responsible for portfolio management of the Fund: Investment Team Senior Member (Length of Service with Fund) Title Focused Equity Thomas Hancock (since the Fund's inception in 2023) Head, Focused Equity Team, GMO.

Focused Equity Ty Cobb (since the Fund's inception in 2023) Portfolio Manager, Focused Equity Team, GMO.

Focused Equity Anthony Hene (since the Fund's inception in 2023) Portfolio Manager, Focused Equity Team, GMO.

Track Record as of Dec 31, 2025

1 Year
Return Before Taxes 21.12%
Return After Taxes on Distributions 20.89%
Return After Taxes on Distributions and Sale of Fund Shares 12.64%
S&P 500 Index (returns reflect no deduction for fees, expenses, or taxes) 17.88%

Holdings as of Aug 31, 2026

44 lines, 42 linked, weights sum to 99.98% · Actively managed (N-CEN)

Holding Ticker / identifier Type Shares Change Weight Market value
Microsoft Corp US5949181045 Equity 795,334 +77,286 7.79% $ 403.465M
Alphabet Inc US02079K3059 Equity 740,929 +72,595 4.86% $ 251.434M
Apple Inc US0378331005 Equity 742,723 +3,892 4.55% $ 235.332M
Johnson & Johnson US4781601046 Equity 853,823 +9,544 4.38% $ 226.989M
Thermo Fisher Scientific Inc US8835561023 Equity 346,497 +77,270 4.13% $ 213.823M
Lam Research Corp US5128073062 Equity 659,259 −102,043 3.84% $ 198.76M
Meta Platforms Inc US30303M1027 Equity 340,194 +32,788 3.76% $ 194.707M
Broadcom Inc US11135F1012 Equity 521,681 +38,844 3.73% $ 193.199M
Amazon.com Inc US0231351067 Equity 720,044 +70,260 3.61% $ 187.046M
Salesforce Inc US79466L3024 Equity 687,508 +88,834 3.42% $ 177.061M
Texas Instruments Inc US8825081040 Equity 673,366 +19,474 3.39% $ 175.688M
Visa Inc US92826C8394 Equity 395,211 +38,643 2.90% $ 149.931M
NVIDIA Corp US67066G1040 Equity 607,934 new +607,934 2.59% $ 134.22M
Netflix Inc US64110L1061 Equity 1,645,087 +759,422 2.58% $ 133.334M
Abbott Laboratories US0028241000 Equity 1,203,746 −840 2.57% $ 132.845M
Eli Lilly & Co US5324571083 Equity 113,212 +10,539 2.53% $ 130.956M
UnitedHealth Group Inc US91324P1021 Equity 335,913 −1,206 2.53% $ 130.808M
Mastercard Inc US57636Q1040 Equity 221,478 +59,058 2.52% $ 130.519M
KLA Corp US4824801009 Equity 711,352 +618,127 2.41% $ 124.807M
Aramark US03852U1060 Equity 2,103,281 +6,709 2.29% $ 118.436M
Accenture PLC
IE00B4BNMY34 Equity 610,861 +59,721 2.24% $ 115.917M
Procter & Gamble Co/The US7427181091 Equity 717,305 −19,278 2.01% $ 104.095M
Coca-Cola Co/The US1912161007 Equity 1,114,845 +108,896 1.91% $ 98.853M
US Bancorp US9029733048 Equity 1,549,965 −467,493 1.84% $ 95.447M
General Electric Co US3696043013 Equity 275,698 +26,933 1.79% $ 92.555M
Hilton Worldwide Holdings Inc US43300A2033 Equity 278,794 −7,222 1.70% $ 88.177M
Merck & Co Inc US58933Y1055 Equity 565,435 −129,031 1.61% $ 83.549M
Cigna Group/The US1255231003 Equity 284,704 +24,604 1.52% $ 78.601M
Elevance Health Inc US0367521038 Equity 191,162 −8,903 1.45% $ 75.039M
Constellation Brands Inc US21036P1084 Equity 552,037 +53,866 1.39% $ 72.107M
Synopsys Inc US8716071076 Equity 155,916 +15,223 1.32% $ 68.539M
Uber Technologies Inc US90353T1007 Equity 867,530 +84,312 1.27% $ 65.629M
TJX Cos Inc/The US8725401090 Equity 469,066 +45,669 1.21% $ 62.813M
Intuitive Surgical Inc US46120E6023 Equity 145,697 +14,052 1.06% $ 54.907M
Quest Diagnostics Inc US74834L1008 Equity 217,286 +21,078 1.01% $ 52.214M
Philip Morris International Inc US7181721090 Equity 272,522 new +272,522 0.99% $ 51.043M
Stryker Corp US8636671013 Equity 148,998 new +148,998 0.93% $ 48.246M
Brown-Forman Corp US1156372096 Equity 1,542,742 +149,888 0.79% $ 40.991M
Roper Technologies Inc US7766961061 Equity 95,046 +9,368 0.78% $ 40.36M
Tradeweb Markets Inc US8926721064 Equity 359,473 +35,130 0.75% $ 38.715M
PTC Inc US69370C1009 Equity 230,117 +22,249 0.69% $ 35.838M
Jack Henry & Associates Inc US4262811015 Equity 142,010 +21,123 0.46% $ 23.845M
Moody's Corp US6153691059 Equity 45,963 +21,165 0.45% $ 23.195M
State Street Global Advisors
US8574928706 Money market 21,955,042.24 +9,104,307.06 0.42% $ 21.955M

Trades May 31, 2026 to Aug 31, 2026

Holding Ticker Action Before After Change Value
NVIDIA Corp New — 607,934 +607,934 $ 134.22M
KLA Corp Bought 93,225 711,352 +618,127 $ 108.45M
Netflix Inc Bought 885,665 1,645,087 +759,422 $ 61.551M
Philip Morris International Inc New — 272,522 +272,522 $ 51.043M
Stryker Corp New — 148,998 +148,998 $ 48.246M
Thermo Fisher Scientific Inc Bought 269,227 346,497 +77,270 $ 47.683M
Microsoft Corp Bought 718,048 795,334 +77,286 $ 39.206M
Mastercard Inc Bought 162,420 221,478 +59,058 $ 34.803M
Lam Research Corp Sold 761,302 659,259 −102,043 $ -30.765M
US Bancorp Sold 2,017,458 1,549,965 −467,493 $ -28.788M
Alphabet Inc Bought 668,334 740,929 +72,595 $ 24.635M
Salesforce Inc Bought 598,674 687,508 +88,834 $ 22.878M
Merck & Co Inc Sold 694,466 565,435 −129,031 $ -19.066M
Meta Platforms Inc Bought 307,406 340,194 +32,788 $ 18.766M
Amazon.com Inc Bought 649,784 720,044 +70,260 $ 18.251M
Visa Inc Bought 356,568 395,211 +38,643 $ 14.66M
Broadcom Inc Bought 482,837 521,681 +38,844 $ 14.385M
Eli Lilly & Co Bought 102,673 113,212 +10,539 $ 12.191M
Accenture PLC
Bought 551,140 610,861 +59,721 $ 11.333M
Moody's Corp Bought 24,798 45,963 +21,165 $ 10.681M
Coca-Cola Co/The Bought 1,005,949 1,114,845 +108,896 $ 9.656M
General Electric Co Bought 248,765 275,698 +26,933 $ 9.042M
Constellation Brands Inc Bought 498,171 552,037 +53,866 $ 7.036M
Cigna Group/The Bought 260,100 284,704 +24,604 $ 6.793M
Synopsys Inc Bought 140,693 155,916 +15,223 $ 6.692M
Uber Technologies Inc Bought 783,218 867,530 +84,312 $ 6.378M
TJX Cos Inc/The Bought 423,397 469,066 +45,669 $ 6.116M
Intuitive Surgical Inc Bought 131,645 145,697 +14,052 $ 5.296M
Texas Instruments Inc Bought 653,892 673,366 +19,474 $ 5.081M
Quest Diagnostics Inc Bought 196,208 217,286 +21,078 $ 5.065M
Brown-Forman Corp Bought 1,392,854 1,542,742 +149,888 $ 3.983M
Roper Technologies Inc Bought 85,678 95,046 +9,368 $ 3.978M
Tradeweb Markets Inc Bought 324,343 359,473 +35,130 $ 3.784M
Jack Henry & Associates Inc Bought 120,887 142,010 +21,123 $ 3.547M
Elevance Health Inc Sold 200,065 191,162 −8,903 $ -3.495M
PTC Inc Bought 207,868 230,117 +22,249 $ 3.465M
Procter & Gamble Co/The Sold 736,583 717,305 −19,278 $ -2.798M
Johnson & Johnson Bought 844,279 853,823 +9,544 $ 2.537M
Hilton Worldwide Holdings Inc Sold 286,016 278,794 −7,222 $ -2.284M
Apple Inc Bought 738,831 742,723 +3,892 $ 1.233M
UnitedHealth Group Inc Sold 337,119 335,913 −1,206 $ -469.628K
Aramark Bought 2,096,572 2,103,281 +6,709 $ 377.784K
Mondelez International Inc Closed 2,592 — −2,592 $ -158.553K
Abbott Laboratories Sold 1,204,586 1,203,746 −840 $ -92.702K

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up